Trials / Conditions / WHO Grade 4 Glioma
WHO Grade 4 Glioma
5 registered clinical trials studyying WHO Grade 4 Glioma — 4 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Study of Tovorafenib in High-Grade Glioma and Diffuse Intrinsic Pontine Glioma (DIPG) NCT07206849 | Nationwide Children's Hospital | Phase 2 |
| Recruiting | An Investigational Scan (Ga-68 PSMA-11 PET/CT) for Detection of Disease Recurrence or Progression in Patients NCT06444412 | Mayo Clinic | Phase 2 |
| Recruiting | Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma NCT07091864 | Mayo Clinic | N/A |
| Recruiting | Anti-GARP Chimeric Antigen Receptor T Cell Therapy for the Treatment of Recurrent Grade III or IV Gliomas NCT06964737 | Ohio State University Comprehensive Cancer Center | Phase 1 |
| Active Not Recruiting | Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Gra NCT03919071 | National Cancer Institute (NCI) | Phase 2 |